Science
From blood to brain: Delivering nucleic acid therapy to the CNS – Science Daily
Researchers have developed a drug delivery platform wherein heteroduplex oligonucleotide drugs conjugated with cholesterol are…

Researchers from Tokyo Medical and Dental University (TMDU), Takeda Pharmaceutical Co., Ltd. and Ionis Pharmaceuticals, USA, show that heteroduplex oligonucleotide drugs conjugated with cholesterol cross the blood-brain barrier effectively with intravenous…
Continue Reading
-
Business18 hours ago
Warning! These ASX 200 shares were just downgraded
-
Business11 hours ago
Macquarie tips 14% upside for this ASX tech stock
-
Noosa News11 hours ago
Vegetables and herbs you can easily and cheaply grow from seeds
-
Business11 hours ago
This ASX 200 media stock is storming 7% higher to 52-week highs. Here’s why.